299 related articles for article (PubMed ID: 20456698)
1. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008).
Eder AF; Herron RM; Strupp A; Dy B; White J; Notari EP; Dodd RY; Benjamin RJ
Transfusion; 2010 Aug; 50(8):1732-42. PubMed ID: 20456698
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
[TBL] [Abstract][Full Text] [Related]
3. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
4. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy.
Eder AF; Dy BA; Perez JM; Rambaud M; Benjamin RJ
Transfusion; 2013 Jul; 53(7):1442-9. PubMed ID: 23113676
[TBL] [Abstract][Full Text] [Related]
5. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
[TBL] [Abstract][Full Text] [Related]
6. Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study.
Middelburg RA; van Stein D; Atsma F; Wiersum-Osselton JC; Porcelijn L; Beckers EA; Briët E; van der Bom JG
Transfusion; 2011 Oct; 51(10):2111-7. PubMed ID: 21985044
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study.
Rana R; Fernández-Pérez ER; Khan SA; Rana S; Winters JL; Lesnick TG; Moore SB; Gajic O
Transfusion; 2006 Sep; 46(9):1478-83. PubMed ID: 16965572
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
Lin Y; Saw CL; Hannach B; Goldman M
Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
[TBL] [Abstract][Full Text] [Related]
9. Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).
Funk MB; Guenay S; Lohmann A; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
Vox Sang; 2012 May; 102(4):317-23. PubMed ID: 21967322
[TBL] [Abstract][Full Text] [Related]
10. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
11. The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines.
Vlaar AP; Wortel K; Binnekade JM; van Oers MH; Beckers E; Gajic O; Schultz MJ; Juffermans NP
Transfusion; 2010 Feb; 50(2):443-51. PubMed ID: 19804567
[TBL] [Abstract][Full Text] [Related]
12. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
13. Transfusion therapy and acute lung injury.
Sokolovic M; Pastores SM
Expert Rev Respir Med; 2010 Jun; 4(3):387-93. PubMed ID: 20524921
[TBL] [Abstract][Full Text] [Related]
14. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.
Ozier Y; Muller JY; Mertes PM; Renaudier P; Aguilon P; Canivet N; Fabrigli P; Rebibo D; Tazerout M; Trophilme C; Willaert B; Caldani C
Transfusion; 2011 Oct; 51(10):2102-10. PubMed ID: 21382042
[TBL] [Abstract][Full Text] [Related]
15. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
16. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis.
Müller MC; van Stein D; Binnekade JM; van Rhenen DJ; Vlaar AP
Transfusion; 2015 Jan; 55(1):164-75. PubMed ID: 25135630
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-related acute lung injury (TRALI): a review of investigations by the National Tissue Typing Laboratory of cases reported in New Zealand since June 2004.
Dunn P; Dinesh D
N Z Med J; 2008 Jun; 121(1276):42-7. PubMed ID: 18574508
[TBL] [Abstract][Full Text] [Related]
18. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
19. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
